Cargando…

17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth – A Systematic Review and Meta-analysis Taking into Account the PROLONG Trial

Background Prior spontaneous preterm birth is a strong risk factor for the recurrence of spontaneous preterm birth in a subsequent pregnancy and has been evaluated in prevention studies using progesterone (natural progesterone administered orally or vaginally, and 17-hydroxyprogesterone caproate [17...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuon, Ruben-J., Berger, Richard, Rath, Werner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815338/ https://www.ncbi.nlm.nih.gov/pubmed/33487666 http://dx.doi.org/10.1055/a-1295-0752

Ejemplares similares

Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
por: Garcia, Stephanie M., et al.
Publicado: (2021)

Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birth
por: Sibai, Baha, et al.
Publicado: (2020)

Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth
por: Rouholamin, Safoura, et al.
Publicado: (2015)

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial
por: Price, Joan T., et al.
Publicado: (2019)

The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
por: Ransom, Carla E., et al.
Publicado: (2011)

Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth
por: Vidaeff, Alex C, et al.
Publicado: (2013)

17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial
por: Combs, C Andrew, et al.
Publicado: (2011)

Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth
por: Travanty, Michael N, et al.
Publicado: (2018)

Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?
por: Cohen, Gal, et al.
Publicado: (2022)

Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial
por: Price, Joan T, et al.
Publicado: (2021)

17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials
por: Baradwan, Saeed, et al.
Publicado: (2021)

Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
por: Sexton, Donal J, et al.
Publicado: (2004)

Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection
por: Chollet, John L., et al.
Publicado: (2012)

Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy
por: Boggess, Kim A., et al.
Publicado: (2018)

Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support
por: SATIR, FUNDA, et al.
Publicado: (2013)

Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth
por: Alizadeh, Fahimeh, et al.
Publicado: (2022)

Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-alpha-Hydroxyprogesterone Caproate
por: Egerman, Robert, et al.
Publicado: (2014)

17α-Hydroxyprogesterone Caproate Inhibits Cytokine Production via Suppression of NF-κB Activation
por: Hu, Tao, et al.
Publicado: (2022)

In Utero Exposure to 17α-Hydroxyprogesterone Caproate May Contribute to Increasing Incidence Rates of Early-Onset Cancer
por: Murphy, Caitlin C, et al.
Publicado: (2021)

Progesterone for the Prevention of Preterm Birth – an Update of Evidence-Based Indications
por: Kuon, Ruben-J., et al.
Publicado: (2019)

17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials
por: Almutairi, Abdulaali R., et al.
Publicado: (2021)

SUN-255 The Synthetic Progestin, 17-alpha-hydroxyprogesterone Caproate, Used in Human Pregnancy Alters Prefrontal Cortical Development in Rats
por: Lolier, Melanie L, et al.
Publicado: (2020)

17-Hydroxyprogesterone caproate improves hypertension and renal endothelin-1 in response to sFlt-1 induced hypertension in pregnant rats
por: Amaral, Lorena M., et al.
Publicado: (2020)

Improving Uptake and Adherence to 17-Hydroxyprogesterone Caproate in Non-Hispanic Black Women: A Mixed Methods Study of Potential Interventions from the Patient Perspective
por: Wheeler, Sarahn M., et al.
Publicado: (2019)

17-α Hydroxyprogesterone Nanoemulsifying Preconcentrate-Loaded Vaginal Tablet: A Novel Non-Invasive Approach for the Prevention of Preterm Birth
por: Patki, Manali, et al.
Publicado: (2019)

Progesterone – Effective for Tocolysis and Maintenance Treatment After Arrested Preterm Labour?: Critical Analysis of the Evidence
por: Rath, Werner, et al.
Publicado: (2019)

Position Paper of the Task Force for Obstetrics and Prenatal Medicine (AGG – Section Preterm Birth) on the Placement, Removal and Surveillance of the Arabin Cervical Pessary in Patients at Risk for Spontaneous Preterm Birth
por: Kyvernitakis, Ioannis, et al.
Publicado: (2019)

Actions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth
por: Kuon, R.-J., et al.
Publicado: (2012)

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
por: Teti, Claudia, et al.
Publicado: (2023)

First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency
por: Itonaga, Tomoyo, et al.
Publicado: (2022)

Comparing intramuscular progesterone, vaginal progesterone and 17 -hydroxyprogestrone caproate in IVF and ICSI cycle
por: Moini, Ashraf, et al.
Publicado: (2011)

Comparison of Risk of Preterm Labor between Vaginal Progesterone and17-Alpha-Hydroxy-Progesterone Caproate in Women with Threatened Abortion: A Randomized Clinical Trial
por: Beigi, Abootaleb, et al.
Publicado: (2016)

High-Dose Hook Effect in 17-Hydroxyprogesterone Assay in a Patient with 21-Hydroxylase Deficiency
por: Parlak, Mesut, et al.
Publicado: (2015)

Individual 17-Hydroxyprogesterone Responses to hCG Are Not Correlated With Follicle Size in Polycystic Ovary Syndrome
por: Homer, Michael V, et al.
Publicado: (2019)

Cortisol, progesterone, 17α-hydroxyprogesterone, and TSH responses in dogs injected with low-dose lipopolysaccharide
por: Corder-Ramos, Nicole L.B., et al.
Publicado: (2019)

17-hydroxyprogesterone quantification in dried blood spots by high performance liquid chromatography-tandem mass spectroscopy
por: Waller, Kate, et al.
Publicado: (2015)

SAT-011 Quantification of Testosterone, Androstenedione and 17-Hydroxyprogesterone Collected Using Mitra®Micro Sampling Devices
por: Marshall, David, et al.
Publicado: (2019)

Simultaneous quantitation of four androgens and 17‐hydroxyprogesterone in polycystic ovarian syndrome patients by LC‐MS/MS
por: Cao, Zheng, et al.
Publicado: (2020)

An integrated PK‐PD model for cortisol and the 17‐hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia
por: Al‐Kofahi, Mahmoud, et al.
Publicado: (2020)

Spontaneous Preterm Birth: Is Prevention with Aspirin Possible?
por: Berger, Richard, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8mmagud6nfchivt1jcvc0p12ct